Locust Wood Capital Advisers, LLC Abbott Laboratories Call Options Transaction History

Locust Wood Capital Advisers, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $4.96 Million - $5.86 Million	-49,600 Reduced 21.35%	182,700 $20.8 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $5.48 Million - $6.05 Million	-50,000 Reduced 17.71%	232,300 $26.4 Million
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $1.46 Million - $1.79 Million	16,200 Added 6.09%	282,300 $31.1 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $25.4 Million - $30.5 Million	266,100 New	266,100 $25.8 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $114,020 - $139,040	-1,000 Reduced 2.49%	39,200 $4.64 Million
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $1.38 Million - $1.52 Million	-11,800 Reduced 22.69%	40,200 $4.75 Million
Q2 2021 Jul 26, 2021	BUY	$105.79 - $124.53 $5.5 Million - $6.48 Million	52,000 New	52,000 $6.03 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Locust Wood Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Locust Wood Capital Advisers, LLC with notifications on news.